Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
0.8372
Oct 23 • 3:59 PM ET Dollar change-0.0069 Percentage change(-0.82%)
Aftermarket Close
0.8092
Aftermarket • 5:00 PM ET Dollar change-0.0280 Percentage change(-3.34%)
Index
-
Market Cap
6.18M
Enterprise Value
18.57M
Income
-14.45M
Sales
0.01M
Book/sh
0.44
Cash/sh
0.19
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
41
IPO
Aug 08, 1996
P/E
-
Forward P/E
-
PEG
-
P/S
617.91
P/B
1.88
P/C
4.35
P/FCF
-
EV/EBITDA
-
EV/Sales
1856.91
Quick Ratio
0.12
Current Ratio
0.13
Debt/Eq
4.21
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-2.53
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
48.74% 23.68%
Sales past 3/5Y
-67.20% 49.61%
EPS Y/Y TTM
51.12%
Sales Y/Y TTM
-87.73%
EPS Q/Q
36.98%
Sales Q/Q
-96.74%
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
75.20%
Insider Trans
-3.26%
Inst Own
2.35%
Inst Trans
8.63%
ROA
-66.48%
ROE
-196.30%
ROIC
-440.15%
Gross Margin
-34987.54%
Oper. Margin
-101210.17%
Profit Margin
-106283.32%
SMA20
-24.67%
SMA50
-36.00%
SMA200
-48.42%
Trades
Shs Outstand
7.38M
Shs Float
1.83M
52W High
3.88 -78.42%
52W Low
0.80 4.65%
Volatility
13.89% 10.49%
ATR (14)
0.11
RSI (14)
19.25
Beta
2.62
Rel Volume
0.15
Avg Volume
187.42K
Volume
28,400
Perf Week
-9.37%
Perf Month
-41.86%
Perf Quarter
-37.05%
Perf Half Y
-52.70%
Perf YTD
-48.95%
Perf Year
-76.84%
Perf 3Y
-94.93%
Perf 5Y
-99.55%
Perf 10Y
-99.26%
Recom
-
Target Price
-
Prev Close
0.84
Price
0.84
Change %
-0.82%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
chiang yao-chungDirectorJun 05 '26Buy2.053,5007,17511,279Jun 09 12:04 PM
chiang yao-chungDirectorJun 03 '26Buy2.132,0004,2607,779Jun 05 04:10 PM
chiang yao-chungDirectorMay 28 '26Buy2.302505755,779Jun 01 04:10 PM
chiang yao-chungDirectorMay 27 '26Buy2.002,0004,0005,529May 29 04:10 PM
lee ting-chuanDirectorMay 26 '26Sale1.90109,988208,977807,417May 27 08:02 PM
Taiwan Carbon Nano Technology 10% OwnerMay 26 '26Sale2.3641,00096,760948,925May 27 08:00 PM
TSAI CHUN-JUNGDirectorMay 26 '26Sale1.8727,71851,833658,199May 27 07:58 PM
TSAI CHUN-JUNGDirectorMay 22 '26Sale1.551,0821,677685,917May 27 07:58 PM
lee ting-chuanDirectorMay 22 '26Sale1.579,30214,604917,405May 26 04:10 PM
lee ting-chuanDirectorMay 21 '26Sale1.569,00014,040926,707May 26 04:10 PM
chiang yao-chungDirectorMay 19 '26Buy1.682,2003,6963,529May 20 04:10 PM
chiang yao-chungDirectorMay 18 '26Buy1.655008251,329May 20 04:10 PM
chiang yao-chungDirectorMay 05 '26Buy1.70129219829May 07 04:10 PM
chiang yao-chungDirectorApr 30 '26Buy1.68200336700May 01 04:10 PM
chiang yao-chungDirectorApr 29 '26Buy1.75100175500May 01 04:10 PM
Taiwan Carbon Nano Technology 10% OwnerJan 28 '26Sale2.1746,00099,806989,925Jan 29 07:32 PM
Taiwan Carbon Nano Technology 10% OwnerJan 08 '26Sale1.808501,5341,036,356Jan 12 04:10 PM
Taiwan Carbon Nano Technology 10% OwnerJan 09 '26Sale1.864318021,035,925Jan 12 04:10 PM
Ainos, Inc. operates as a dual-platform biotech company, which engages in the development of artificial intelligence-enabled olfactory sensing technologies and immune therapeutics. The firm primarily focuses on the commercialization of AI Nose, an AI-based electronic olfaction system. It continues to develop VELDONA, a low-dose oral interferon platform. The company was founded on June 26, 1984 and is headquartered in Houston, TX.
CEOMr. Chun-Hsien Tsai
Chief Financial OfficerMr. Hsin-Liang Lee
Director of Corporate DevelopomentMr. Chih-Heng Lu